Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001088255 | SCV000641391 | likely benign | Myopathy, proximal, and ophthalmoplegia | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000594531 | SCV000703938 | uncertain significance | not provided | 2016-12-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000594531 | SCV003805438 | uncertain significance | not provided | 2023-02-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Revvity Omics, |
RCV001088255 | SCV003809501 | uncertain significance | Myopathy, proximal, and ophthalmoplegia | 2019-08-02 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000594531 | SCV005622101 | uncertain significance | not provided | 2024-06-11 | criteria provided, single submitter | clinical testing | Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity. (http://gnomad.broadinstitute.org) Polyphen and MutationTaster predict this amino acid change may be benign. |